No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cisplatin / administration & dosage
-
Cyclophosphamide / administration & dosage
-
Cytarabine / administration & dosage
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives
-
Dexamethasone / administration & dosage
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Genetic Markers
-
Genetic Testing
-
Hodgkin Disease / diagnosis
-
Hodgkin Disease / drug therapy*
-
Hodgkin Disease / genetics
-
Humans
-
Leukemia-Lymphoma, Adult T-Cell / diagnosis
-
Leukemia-Lymphoma, Adult T-Cell / drug therapy*
-
Leukemia-Lymphoma, Adult T-Cell / genetics
-
Lymphoma, Non-Hodgkin / diagnosis
-
Lymphoma, Non-Hodgkin / drug therapy*
-
Lymphoma, Non-Hodgkin / genetics
-
Methylprednisolone / administration & dosage
-
Positron-Emission Tomography
-
Prednisone / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Genetic Markers
-
Cytarabine
-
Deoxycytidine
-
Vincristine
-
Etoposide
-
Dexamethasone
-
Doxorubicin
-
Cyclophosphamide
-
Cisplatin
-
Prednisone
-
Methylprednisolone
Supplementary concepts
-
CHOP protocol
-
DHAP protocol
-
EPOCH protocol
-
ESAP protocol
-
GDP protocol